Objectives: This is a protocol for a Cochrane Review (intervention). The objectives are as follows:. The main objective is to assess the benefits and harms of rituximab compared to placebo or another DMT for people with multiple sclerosis. Specific comparisons include:. rituximab compared with placebo or other DMTs as first choice treatment for relapsing forms of MS; rituximab when switching from another DMT compared with placebo or other DMTs for relapsing forms of MS; rituximab compared with placebo or other DMTs as first choice treatment for progressive forms of MS; and rituximab when switching from another DMT compared with placebo or other DMTs for progressive forms of MS.

Rituximab for people with multiple sclerosis / Filippini, G.; Kruja, J.; He, D.; Del Giovane, C.. - In: COCHRANE LIBRARY. - ISSN 1465-1858. - 2021:3(2021), pp. N/A-N/A. [10.1002/14651858.CD013874]

Rituximab for people with multiple sclerosis

Filippini G.;Del Giovane C.
2021

Abstract

Objectives: This is a protocol for a Cochrane Review (intervention). The objectives are as follows:. The main objective is to assess the benefits and harms of rituximab compared to placebo or another DMT for people with multiple sclerosis. Specific comparisons include:. rituximab compared with placebo or other DMTs as first choice treatment for relapsing forms of MS; rituximab when switching from another DMT compared with placebo or other DMTs for relapsing forms of MS; rituximab compared with placebo or other DMTs as first choice treatment for progressive forms of MS; and rituximab when switching from another DMT compared with placebo or other DMTs for progressive forms of MS.
2021
2021
3
N/A
N/A
Rituximab for people with multiple sclerosis / Filippini, G.; Kruja, J.; He, D.; Del Giovane, C.. - In: COCHRANE LIBRARY. - ISSN 1465-1858. - 2021:3(2021), pp. N/A-N/A. [10.1002/14651858.CD013874]
Filippini, G.; Kruja, J.; He, D.; Del Giovane, C.
File in questo prodotto:
File Dimensione Formato  
14651858.cd013874.pdf

Accesso riservato

Tipologia: Versione pubblicata dall'editore
Dimensione 261.18 kB
Formato Adobe PDF
261.18 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

Licenza Creative Commons
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11380/1279473
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 4
  • ???jsp.display-item.citation.isi??? ND
social impact